Although current estimates suggest that one third of the world's population is infected with Mycobacterium tuberculosis, the majority of such infections remain clinically latent. Factors that contribute to the success of M. tuberculosis as a pathogen include its ability to resist the harsh environment of the host macrophage and to persist within immunocompetent hosts even after a clinical cure of the disease is achieved.
The ability of M. tuberculosis to cause disease in the human or animal host may vary according to host susceptibility and to intrinsic biologic differences among clinical strains. The latter may reflect a particular strain's specific adaptation to the antimicrobial defenses of the host macrophage. For example, numerous studies have demonstrated that strains of Mycobacterium differ in susceptibility to reactive oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI) (7, 12, 16, 17, 18, 20, 23, 26) .
The role of ROI and RNI in controlling acute infections with M. tuberculosis has been fairly well studied in the murine system (1, 3, 4, 8, 9, 10, 19) . However, little is known about the role of these intermediates during latent infections. Studies have demonstrated that the inducible form of nitric oxide synthase (iNOS) expression is required to control mycobacterial infection in mice (1, 9, 13, 19) . However, the induction of iNOS does not lead to complete elimination of M. tuberculosis in vivo (22) . In addition, Flynn et al. (11) demonstrated that M. tuberculosis reactivation occurs if the production of RNI is inhibited in a murine model of latency (11) . This suggests that reactivation tuberculosis may result from the removal of host defense mechanisms, such as RNI, that keep M. tuberculosis from replicating in vivo. Consequently, it is possible that ROI and RNI may inhibit replication (bacteriostatic) but do not eradicate the bacteria (bactericidal). We decided to test this concept in vitro by using RNI and ROI susceptibility assays applied to both clinical and laboratory strains of mycobacteria.
MATERIALS AND METHODS
The mycobacterial strains used in the present study are listed in Table 1 . All strains of Mycobacterium were grown in Middlebrook 7H9 broth with 0.5% glycerol, 0.02% Tween 80, and 10% ADC enrichment to mid-log phase. Singlecell suspensions of each isolate were prepared according to a previously published method (15) and quantified by enumeration of their CFU on Middlebrook 7H11 agar plates. A 0.1-ml aliquot of this suspension was added to 0.9 ml of 7H9 broth (pH 5.3 for ASN assays or pH 7.0 for H 2 O 2 assays) containing various concentrations of either sodium nitrite (NaNO 2 ) or hydrogen peroxide (H 2 O 2 ). As a control, the culture was added to 7H9 broth at the appropriate pH without NaNO 2 or H 2 O 2 (unexposed). Each suspension was incubated at 37°C for 24 h, plated onto 7H11 agar, and incubated at 37°C for 3 weeks. At day 21 (or day 26 for H37Ra), the CFU recovered from isolates exposed to either ASN or H 2 O 2 were marked, quantified, and compared to the CFU for recovered isolates not exposed to ASN or H 2 O 2 ; the data were then calculated as the percent survival ([number of CFU exposed at day 21/number of CFU unexposed at day 21] ϫ 100). Incubation at 37°C was allowed to continue to day 50, at which time each plate was reexamined to enumerate additional CFU recovered during the interval. The total number of CFU was again compared to the total number of CFU from recovered isolates not exposed to ASN or H 2 O 2 at 50 days of incubation, and the data were converted to percent survival ([number of CFU exposed at day 50/number of CFU unexposed at day 50] ϫ 100). Each strain was tested similarly in triplicate, and each assay was repeated at least twice. Comparison of the mean CFU recovery of each strain was made by Student t test, and a P value of Ͻ0.05 was considered to show a significant difference.
RESULTS
Each strain of mycobacteria demonstrated similar levels of growth between days 21 and 50 when not exposed to ASN or H 2 O 2 ( Fig. 1A and 2A) . At day 21, at a lower concentration of ASN (3 mM), the percent survival of all strains of mycobacteria was Յ80% compared to the same strains not exposed to ASN. At day 50, however, the percent survival of all of the clinical strains exceeded 80% (Fig. 1A) . Compared to the laboratory strain H37Ra, at 3 mM ASN all of the clinical strains of M. tuberculosis and M. bovis (Ravenel and BCG) were significantly more resistant at day 21 or 50 of incubation (P Ͻ 0.05, Student t test) ( Fig. 1B and Table 2 ). In addition, at 3 mM ASN the percent survival at day 21 versus that at day 50 was significantly different for each strain. On the other hand, at a higher concentration of ASN (6 mM), the percent survival of the strains at days 21 and 50 showed no significant difference, except for H37Ra and M. bovis Ravenel (Fig. 1B) . At 6 mM ASN all of the strains, except M. bovis BCG, remained relatively resistant compared to H37Ra (Table 2) .
At 2 mM H 2 O 2 , H37Ra and one clinical isolate (C.C.13) were most susceptible compared to the other strains tested, but no significant difference was detected between the two time points of incubation for each strain, except with H37Ra ( (Fig. 2B) . Two of the clinical isolates (CB3.3 and CDC1551) consistently exhibited the highest resistance to killing by 5 mM H 2 O 2 or 6 mM ASN compared to all of the other strains tested in the present study ( Fig. 1B and 2B) .
DISCUSSION
Our results demonstrate that, at a low concentration of ASN, the tested Mycobacterium strains display a greater level of variation in percent survival at 21 days of incubation compared to that observed at 50 days of incubation. However, at high concentrations of ASN, these differences in the percent survival at both day 21 and day 50 disappeared for each strain. Significant differences in the percent survival of the clinical isolates at the two time points were not observed when they were exposed to either concentration of H 2 O 2 . These data suggest that the RNI products, but not H 2 O 2 , exert a bacteriostatic effect at low concentrations and a bactericidal effect at high concentrations.
Considering that most mycobacterial strains were able to recover from exposure to lower concentrations of ASN when allowed to incubate beyond 3 weeks, it appears that the time of incubation after which CFU data are analyzed is important when similar assays are used to determine mycobacterial susceptibility to any type of stress. Although all of the strains in the present study exhibited some level of recovery to low concentrations of H 2 O 2 , the differences in the percent survival between day 21 and day 50 within each strain were not statistically significant, with the exception of one strain (H37Ra). (2, 16, 21) . Since H37Ra has a much slower growth rate than the other strains used, the significant level of recovery seen at all concentrations of ASN and H 2 O 2 may be a consequence of not being able to visualize the colonies until much later. We tried to minimize this effect by determining the initial CFU of H37Ra at day 26 instead of at day 21, thus allowing the organism sufficient time to grow. Collectively, our data indicate that under the in vitro conditions used here exposure to low concentrations of ASN resulted in the stasis of most clinical isolates of M. tuberculosis. In contrast to these data, a study by Chan et al. (2) found that chemically generated RNI at concentrations of between 1.0 and 10 mM are bactericidal to M. tuberculosis in vitro (2), although it should be noted that only one strain (Erdman) was analyzed and that the incubation period after which CFU were enumerated was not clearly defined. Our results are consistent with those of Rhoades and Orme (24) , who demonstrated in vitro that the antimycobacterial activity of interferon-primed macrophages was bacteriostatic rather than bactericidal (24) . In addition, Rhoades and Orme found that a high concentration (10 mM) of NaNO 2 was mycobactericidal in a cell-free system and that lower concentrations (0.1 to 5.0 mM) showed a range of tolerance by clinical mycobacterial isolates (24) . It should be noted that the cell-free assay used in the Rhoads and Orme study, although similar, was not identical to ours. Our study exposed mycobacterial strains for 16 h as opposed to a period of 10 days, and the CFU in the Rhoades and Orme study were determined at between 3 and 4 weeks.
Despite (6, 12, 25) . These observations are consistent with numerous studies that have demonstrated strain-related differences regarding susceptibility to RNI and ROI (7, 12, 16, 17, 18, 20, 23, 24, 26) (14) are generated. Hence, the amount of ROI and RNI added in the cell-free system used in the present study is higher than that expected to be generated in vivo. Therefore, relatively resistant M. tuberculosis strains, such as CB3.3 and CDC1551, are less likely to be kept in check within the host. Consequently, one could postulate that such strains are more capable of causing active disease more readily after an initial infection than strains that are relatively susceptible to RNI and ROI. In contrast, the proliferation of RNI-and ROI-susceptible strains may be controlled as long as the host is able to maintain RNI and/or ROI expression. In the absence of these stresses, such M. tuberculosis strains may resume proliferation and cause the reactivation of disease.
While there may be multiple other host factors that contribute to bacteriostasis of M. tuberculosis in vivo, the observation of the bacteriostatic effect of RNI made in vitro, as well as the wide range of RNI and/or ROI susceptibilities of the clinical isolates, may provide new clues about the different clinical outcomes after M. tuberculosis infection.
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